ClinicalTrials.Veeva

Menu

Pain Control for Cervical Ripening Balloon

Beth Israel Lahey Health logo

Beth Israel Lahey Health

Status and phase

Not yet enrolling
Phase 2

Conditions

Labor Induction

Treatments

Drug: topical vaginal application lidocaine gel

Study type

Interventional

Funder types

Other

Identifiers

NCT07268118
2025P000734

Details and patient eligibility

About

No standard of care exists for pain management during cervical ripening balloon placement. The purpose of this study is to evaluate if vaginal topical lidocaine reduces pain related to cervical ripening balloon placement during induction of labor.

Enrollment

110 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥18 years
  • Gestational age ≥37 weeks
  • Viable pregnancy
  • Intact membranes
  • English speaking
  • Interested in cervical ripening balloon placement
  • Able to provide consent

Exclusion criteria

  • Allergy or sensitivity to lidocaine
  • Patients that already have neuraxial anesthesia (i.e. spinal, epidural, combined spinal/epidural)
  • Known uterine or cervical anomalies

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

110 participants in 2 patient groups

Topical lidocaine
Experimental group
Treatment:
Drug: topical vaginal application lidocaine gel
Standard of care
No Intervention group

Trial contacts and locations

0

Loading...

Central trial contact

Sarah Little, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems